Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assaysResearch Article Published on 2020-10-172022-10-31 Journal: Emerging Microbes & Infections [Category] COVID-19, MERS, SARS, [키워드] antibody biosafety cell tropism Characteristics convalescent COVID-19 patients correlated COVID-19 vaccine develop Entry G glycoprotein highly pathogenic Neutralization assay neutralized Neutralizing titer Particles promote Protein pseudoviruses replication-competent S protein Safe SARS-CoV-2 SARS-CoV-2 entry sera stomatitis vesicular stomatitis virus virus virus VSV wild type wild-type [DOI] 10.1080/22221751.2020.1830715 PMC 바로가기 [Article Type] Research Article
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent IndividualsObservation Published on 2020-10-162022-10-29 Journal: mBio [Category] COVID-19, MERS, SARS, [키워드] absence acute COVID-19 acute respiratory syndrome analysis approach Clinical efficacy clinical trial collected convalescent convalescent individual convalescent plasma convalescent plasma trial coronavirus coronavirus disease COVID-19 COVID-19 patient cross-reactivity D614G variant Decline Donor effective vaccine Efficacy ELISA evaluate for inclusion globe glycoprotein Humoral response IgA IgG IgM individual Infection interval neutralization neutralization activity neutralize Neutralizing activity neutralizing antibody Neutralizing titer onset of symptom patients performed plasma plasma neutralization activity positive Prevent PROTECT pseudoparticle RBD repeated required resolution of symptoms response Safe SARS-CoV-2 SARS-COV-2 infection significant decrease spike spike glycoproteins Symptoms therapeutic options therapy thought transfer transfusion treat Treatment Vaccine while wild-type SARS-CoV-2 [DOI] 10.1128/mBio.02590-20 PMC 바로가기 [Article Type] Observation
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodArticle Published on 2020-09-172022-10-04 Journal: Nature Communications [Category] SARS, 진단, [키워드] Anti-spike antibody Antibody test Area assays Blood blood donor COVID-19 patients Diagnostic markers Donor Epidemiology Evidence hospitalized patient IgG IgM Immunoglobulin in vitro indication less median time Neutralising activity Neutralizing activity Neutralizing antibody titer neutralizing capacity Neutralizing titer Patient Population populations positive Predictive Protein ranged remained San Francisco Bay SARS-CoV-2 SARS-CoV-2 seroprevalence SARS-CoV-2-specific antibody Seroconversion Serological testing Surveillance symptom onset viral infection [DOI] 10.1038/s41467-020-18468-8 PMC 바로가기 [Article Type] Article
Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?Article Published on 2020-07-072022-10-28 Journal: Viruses [Category] COVID-19, SARS, [키워드] coronavirus COVID-19 decrease detection diagnostics drastic ELISA ELISA test European evaluated heat heat inactivation human sera IgG inactivation infected cell culture limit of detection molecular nasopharyngeal sample neutralization Neutralizing titer Precaution protocol recommendation reduce reduced reduction risk RNA copy SARS-CoV-2 SARS-CoV-2 transmission serology serum specimen Standard supernatant TCID TCID50 Treatment Type undergo Viral load virus neutralization test [DOI] 10.3390/v12070735 PMC 바로가기 [Article Type] Article
Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with PseudotypesResearch Published on 2005-03-012022-10-31 Journal: Emerging Infectious Diseases [Category] Coronavirus, [키워드] 2003 229E against SARS-CoV antibody coronavirus coronavirus strain correlated cross-neutralization determine develop emerging handling Hong Kong human sera Immunity in vitro Infectious diseases long-lasting microneutralization natural infection neutralization tests Neutralizing antibodies Neutralizing antibody response Neutralizing titer NO OC43 occurred outbreak Profiling pseudotype recovered patients Research response SARS patient SARS virus SARS-CoV SARS-CoV neutralizing antibodies SARS-CoV S SARS-CoV spike protein serum sample Spike protein Vaccines was used [DOI] 10.3201/eid1103.040906 PMC 바로가기 [Article Type] Research